Back4d Pharma Plc Overview

4d Pharma Plc Current Cash

4d Pharma Plc's current cash is $21M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$20.97M
↑ 139.01% YoYΔ $12.20M vs prior year quarter

Peer average

Loading

4d Pharma Plc Current Cash History

Loading

4d Pharma Plc vs. peers: Current Cash Comparison

Loading

4d Pharma Plc Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

4d Pharma Plc (LBPS) FAQ

4d Pharma Plc (LBPS) currently reports a current cash of $21M as of December 2021. That compares with $8.8M in the prior-year period — up 139.0% year over year. Use the charts on this page to explore 4d Pharma Plc's current cash history and peer comparisons.

4d Pharma Plc's current cash increased from $8.8M to $21M — a 139.0% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

4d Pharma Plc reported $21M in current cash as of December 2021. That compares with $8.8M in the prior-year period — up 139.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 4d Pharma Plc, and consider following LBPS for alerts when major investors trade the stock.

4d Pharma Plc is classified in the Healthcare sector. On current cash, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBPS with unrelated industries.